| AKI stage 1 (n = 8) | AKI stage 2 (n = 7) | AKI stage 3 (n = 16) | P-value |
---|---|---|---|---|
Age (year) a | 11 (0.75–15) | 9.5 (4–17) | 7.1 (1–15.3) | 0.893 |
Gender b Male/Female | 4 (50%)/4 (50%) | 5 (71.4%)/ 2 (28.6%) | 10 (62.5%)/ 6 (37.5%) | 0.690 |
Weight (kg) a | 28.5 (7.3–63) | 27 (15–57) | 23 (9–71) | 0.833 |
Height (cm) c | 124.5 ± 38.6 | 117.7 ± 24.6 | 120.9 ± 32.1 | 0.921 |
BMI (kg/m2) c | 17.5 ± 4.5 | 17.8 ± 2.1 | 19.8 ± 4 | 0.323 |
Co-morbid diseases b | 1 (12.5%) | 1 (14.3%) | 7 (43.8%) | 0.175 |
Presenting features b | ||||
 Fever | 8 (100%) | 7 (100%) | 12 (75%) | 0.116 |
 Dyspnoea | 8 (100%) | 7 (100%) | 10 (62.5%) | 0.031 |
 GIT symptoms | 4 (50%) | 3 (42.9%) | 10 (62.5%) | 0.650 |
 Rash | 0 | 0 | 3 (18.8%) | 0.211 |
System affection associating AKI b | ||||
 Cardiac | 4 | 3 | 4 | 0.434 |
 Respiratory | 8 | 7 | 10 | 0.031 |
 Gastro-intestinal | 2 | 3 | 4 | 0.657 |
 Hematologic | 6 | 5 | 12 | 0.982 |
 Neurologic | 0 | 3 | 7 | 0.077 |
 Dermatologic | 0 | 0 | 3 | 0.211 |
 Vasopressors use b | 1 (12.5%) | 2 (28.6%) | 2 (12.5%) | 0.596 |
 Oxygen therapy b | 5 (62.5%) | 5 (71.4%) | 5 (31.3%) | 0.135 |
 Invasive Mechanical Ventilation b | 3 (37.5%) | 2 (28.6%) | 8 (50%) | 0.605 |
 Duration of Mechanical Ventilation(days) c | 6.7 ± 4.7 | 8 ± 1.4 | 7.4 ± 3.5 | 0.921 |